Freenome

Early cancer detection company developing blood-based screening tests using multiomics and AI; SimpleScreen CRC received FDA approval in July 2026.

Back to company catalog

Cancer Screening · Blood-based multiomics / AI / machine learning · Commercial

Compare report options